PMID- 21256182 OWN - NLM STAT- MEDLINE DCOM- 20110620 LR - 20181201 IS - 1872-8057 (Electronic) IS - 0303-7207 (Linking) VI - 335 IP - 2 DP - 2011 Mar 30 TI - Regulation of Sertoli cell activin A and inhibin B by tumour necrosis factor alpha and interleukin 1alpha: interaction with follicle-stimulating hormone/adenosine 3',5'-cyclic phosphate signalling. PG - 195-203 LID - 10.1016/j.mce.2011.01.014 [doi] AB - Regulation of crucial events during spermatogenesis involves dynamic changes in cytokine production and interactions across the cycle of the seminiferous epithelium. Regulation of activin A and inhibin B production by the inflammatory cytokines, tumour necrosis factor alpha (TNFalpha) and interleukin 1alpha (IL1alpha), alone and in conjunction with FSH or a cAMP analogue (dibutyryl cAMP), was examined in cultures of Sertoli cells from 20-day old rats. Both TNFalpha and IL1alpha stimulated activin A secretion and expression of its subunit (beta(A)) mRNA, and suppressed inhibin B secretion and expression of its subunit (alpha and beta(B)) mRNAs. The actions of TNFalpha and IL1alpha were opposed by FSH and dibutyryl cAMP. Both cytokines inhibited FSH/dibutyryl cAMP-stimulated inhibin B secretion and mRNA expression as well as stem cell factor mRNA expression. Both cytokines also inhibited FSH-induced cAMP production, and reduced baseline FSH receptor mRNA expression. These data highlight the reciprocal relationship that exists between FSH/cAMP signalling and inflammatory cytokine signalling pathways in the control of Sertoli cell function, and production of activin A/inhibin B in particular. It is anticipated that these interactions play important roles in the fine control of events during the cycle of the seminiferous epithelium and in the inhibition of spermatogenesis during inflammation. CI - Crown Copyright (c) 2011. Published by Elsevier Ireland Ltd. All rights reserved. FAU - Kazutaka, Saito AU - Kazutaka S AD - Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia. FAU - Winnall, Wendy R AU - Winnall WR FAU - Muir, Julie A AU - Muir JA FAU - Hedger, Mark P AU - Hedger MP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110120 PL - Ireland TA - Mol Cell Endocrinol JT - Molecular and cellular endocrinology JID - 7500844 RN - 0 (Interleukin-1alpha) RN - 0 (N-acetylsphingosine) RN - 0 (Phosphodiesterase Inhibitors) RN - 0 (Protein Subunits) RN - 0 (Receptors, FSH) RN - 0 (Recombinant Proteins) RN - 0 (Stem Cell Factor) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (inhibin B) RN - 0 (inhibin beta A subunit) RN - 57285-09-3 (Inhibins) RN - 63X7MBT2LQ (Bucladesine) RN - 9002-68-0 (Follicle Stimulating Hormone) RN - 93443-12-0 (Inhibin-beta Subunits) RN - E0399OZS9N (Cyclic AMP) RN - NGZ37HRE42 (Sphingosine) SB - IM MH - Animals MH - Bucladesine/pharmacology MH - Cells, Cultured MH - Cyclic AMP/antagonists & inhibitors/*metabolism MH - Down-Regulation MH - Follicle Stimulating Hormone/*pharmacology/physiology MH - Inhibin-beta Subunits/genetics/*metabolism MH - Inhibins/genetics/*metabolism MH - Interleukin-1alpha/*pharmacology/physiology MH - Male MH - Phosphodiesterase Inhibitors/pharmacology MH - Protein Subunits/genetics/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, FSH/genetics MH - Recombinant Proteins/pharmacology MH - Sertoli Cells MH - Signal Transduction MH - Sphingosine/analogs & derivatives/pharmacology MH - Stem Cell Factor/genetics MH - Transcription, Genetic MH - Tumor Necrosis Factor-alpha/*pharmacology/physiology MH - Up-Regulation EDAT- 2011/01/25 06:00 MHDA- 2011/06/21 06:00 CRDT- 2011/01/25 06:00 PHST- 2010/10/14 00:00 [received] PHST- 2011/01/13 00:00 [revised] PHST- 2011/01/14 00:00 [accepted] PHST- 2011/01/25 06:00 [entrez] PHST- 2011/01/25 06:00 [pubmed] PHST- 2011/06/21 06:00 [medline] AID - S0303-7207(11)00036-0 [pii] AID - 10.1016/j.mce.2011.01.014 [doi] PST - ppublish SO - Mol Cell Endocrinol. 2011 Mar 30;335(2):195-203. doi: 10.1016/j.mce.2011.01.014. Epub 2011 Jan 20.